top of page

Neurohormonal blockade in HFrEF, we use

  • Writer: Mayta
    Mayta
  • Jan 10, 2024
  • 1 min read
  • ARNI: Sacubitril/Valsartan, which enhances natriuretic peptides and blocks angiotensin II effects, reducing blood pressure and fluid overload.

  • ACE Inhibitors: Lisinopril, Enalapril, Ramipril, which prevent the formation of angiotensin II, leading to vasodilation and reduced cardiac workload.

  • ARBs: Losartan, Valsartan, Candesartan, which block angiotensin II receptors, decreasing vasoconstriction and sodium retention.

  • Beta-Blockers: Carvedilol, Bisoprolol, Metoprolol Succinate, which slow heart rate and reduce myocardial oxygen demand.

  • MRAs: Spironolactone, Eplerenone, which counteract aldosterone, reducing fluid retention and cardiac remodeling.

  • SGLT2 Inhibitors: Dapagliflozin, Empagliflozin, Canagliflozin, which cause glucose excretion and have beneficial effects on cardiac function and hospitalization rates.

 
 
 

Recent Posts

See All

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
Post: Blog2_Post

​Message for International and Thai Readers Understanding My Medical Context in Thailand

Message for International and Thai Readers Understanding My Broader Content Beyond Medicine

bottom of page